Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment
Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]
Lance Baldo Joins Freenome as Chief Medical Officer
Freenome, a privately held biotech company, announced today that Lance Baldo, M.D. has joined the […]
Freenome Launches The Vallania Study For The Early Detection Of Multiple Cancers
Freenome, a privately held biotech company, today announced the initiation of Vallania, a clinical study […]
Freenome Presents Research Highlighting its Multiomics Blood Testing Platform in PREEMPT CRC
Freenome, a privately held biotech company, presented at the American Society of Clinical Oncology Gastrointestinal […]
Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer
Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]
Freenome Raises $300M in Series D Financing to Advance Multiomics Platform for Early Cancer Detection
Freenome, a privately held biotech company, today announced a Series D funding of $300 million. […]
Freenome Shows Continued Leadership in Colorectal Cancer Research
Freenome, a privately held biotech company, presented new research at the American College of Gastroenterology […]
New Study Finds Freenome ’s Multiomics Approach Successful in Detecting Pancreatic Cancer
Freenome, a privately-held biotech company, presented new research today at the American Association of Cancer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more